![](https://investorshub.advfn.com/uicon/138434.png?cb=1464725830)
Thursday, March 30, 2023 7:01:42 PM
The companies he gave as examples were Atea Pharmaceuticals, Appili Therapeutics, CytoDyn, and Humanigen, etc.
Thanks. Interesting how he’s blaming the fda. Plenty folks here had both sides of that coin. They said fda is corrupt while saying also the fda was working with rvv on steps toward approval
I would think if they couldn’t get it done as MF stated then why waste time and money and simply partner or license to a BP?? If they don’t then all hope is lost and the drug isn’t what it seems
Sure this is now option 4 in the PR so maybe one day folks will wake up to a pps above 1.00 with news of some arrangement
Gltu
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM